Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Coldrif case: ED attaches assets worth over Rs 2 crore of Sresan Pharma proprietor

Ruchika Sharma4 Dec 2025 4:29 PM IST

New Delhi: Directorate of Enforcement (ED), Chennai Zonal Office has made a major move against G. Ranganathan, the proprietor of Sresan...

Lupin enter into licensing agreement with Valorum for biosimilar Armlupeg in US

Lupin enters into licensing agreement with Valorum for biosimilar Armlupeg in US

Ruchika Sharma4 Dec 2025 2:14 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has entered into an Exclusive Licensing Agreement with Valorum Biologics, a ...

Zydus receives USFDA EIR for Jarod injectable facility

USFDA issues EIR for Zydus Jarod injectable facility

Ruchika Sharma4 Dec 2025 1:14 PM IST

Ahmedabad: Zydus has announced that the company has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug...

Granules India packaging facility in US successfully completes USFDA inspection

Ruchika Sharma4 Dec 2025 12:52 PM IST

Hyderabad: Granules India has announced that its US step-down subsidiary, Granules Consumer Health, a wholly-owned subsidiary of Granules...

USFDA-Telangana DCA meet to discuss future activities

Ruchika Sharma4 Dec 2025 12:36 PM IST

Hyderabad: Senior officials from the U.S. Food and Drug Administration (USFDA) recently held a meeting with the Drugs Control Administration,...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly Jaypirca secures USFDA approval for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor

Ruchika Sharma4 Dec 2025 11:30 AM IST

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted approval to Jaypirca...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Sandoz unveils denosumab biosimilars in Europe

Ruchika Sharma4 Dec 2025 10:30 AM IST

Basel: Sandoz has announced the European launch of Wyost (denosumab 120 mg) and Jubbonti (denosumab 60 mg). The medicines are among the first...

Gurgaon Health Dept Bans Mifepristone-Misoprostol Sales, Warns Chemists of Penal Action

Odisha ramps up drive against illegal sale of MTP kits

Ruchika Sharma3 Dec 2025 6:23 PM IST

Bhubaneshwar: In a major push to protect public health, the State Health and Family Welfare Department has intensified the state-wide drive on...

JnJ Imaavy gets European Commission approval for generalised myasthenia gravis

Ruchika Sharma3 Dec 2025 2:30 PM IST

Beerse: Johnson & Johnson has announced that the European Commission has approved a Marketing Authorisation for IMAAVY (nipocalimab), a...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Ruchika Sharma3 Dec 2025 1:19 PM IST

Bengaluru: Strides Pharma Science has announced that the company has appointed Nandini Matiyani as Executive Vice President - Human...

Big investment push: Sun Pharma Labs to set up Rs 3000 crore facility in MP

Ruchika Sharma3 Dec 2025 12:30 PM IST

Mumbai: Sun Pharma Laboratories Limited, a wholly owned subsidiary of Sun Pharma, is set to establish a Rs 3,000-crore greenfield formulations...

USFDA Announces Major Push to Speed Biosimilar Development, Slash Biologic Drug Costs

Astrazeneca Baxdrostat application accepted for priority review by USFDA for hard-to-control hypertension

Ruchika Sharma3 Dec 2025 11:30 AM IST

Cambridge: AstraZeneca has announced that its New Drug Application (NDA) for baxdrostat has been accepted for Priority Review by the US Food and...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok